Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass

The current literature recognises that left ventricular hypertrophy makes a key contribution to the high rate of premature cardiovascular mortality in dialysis patients. Determining how we might intervene to ameliorate left ventricular hypertrophy in dialysis populations has become a research priori...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC nephrology 2013-07, Vol.14 (1), p.149-149, Article 149
Hauptverfasser:	Dunlop, Joanna Leigh, Vandal, Alain Charles, de Zoysa, Janak Rashme, Gabriel, Ruvin Sampath, Haloob, Imad Adbi, Hood, Christopher John, Matheson, Philip James, McGregor, David Owen Ross, Rabindranath, Kannaiyan Samuel, Semple, David John, Marshall, Mark Roger
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood pressure Care and treatment Clinical trials Dialysis Solutions - administration & dosage Dialysis Solutions - chemistry Environmental science Follow-Up Studies Health aspects Health sciences Heart enlargement Hemodialysis Hemodialysis, Home - adverse effects Hemodialysis, Home - methods Humans Hypertrophy, Left Ventricular - epidemiology Hypertrophy, Left Ventricular - prevention & control Kidney diseases Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - therapy Medical research Medicine Medicine, Experimental Mortality Nephrology New Zealand - epidemiology Physiological aspects Population Prospective Studies Renal Dialysis - adverse effects Renal Dialysis - methods Risk factors Single-Blind Method Smoking Sodium - administration & dosage Sodium - chemistry Sodium metabolism Study Protocol Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!